active ankylosing spondylitis
Showing 1 - 5 of 5
Active Ankylosing Spondylitis Trial (VC005 tablets, Tofacitinib Citrate Tablets, VC005 Tablets Placebo)
Not yet recruiting
- Active Ankylosing Spondylitis
- VC005 tablets
- +2 more
- (no location specified)
Apr 4, 2023
Korean Post-marketing Surveillance for Xeljanz XR
Recruiting
- Active Moderate to Severe Rheumatoid Arthritis
- Active Ankylosing Spondylitis
- Tofacitinib XR
-
Seoul, Korea, Republic ofPfizer
Oct 10, 2022
Active Ankylosing Spondylitis Trial in China (JS005, Placebo)
Recruiting
- Active Ankylosing Spondylitis
- JS005
- Placebo
-
Hefei, Anhui, China
- +22 more
Jan 23, 2022
Moderate and Severe Active Rheumatoid Arthritis, Active Psoriatic Arthritis, Active Ankylosing Spondylitis Trial in United
Completed
- Moderate and Severe Active Rheumatoid Arthritis
- +3 more
-
Mesa, Arizona
- +21 more
Oct 4, 2019